Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a minor update to the page version without altering study details or results.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s version/revision label was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study record content.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedA new site revision label 'Revision: v3.5.0' is displayed and the previous 'Revision: v3.4.3' label is removed.SummaryDifference0.0%

- Check76 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check105 days agoChange DetectedAdded site revision tag v3.4.2 and removed the earlier government-funding notice; this is an administrative update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.